We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

89 hedge funds and large institutions have $255M invested in BioSpecifics Technologies Corp. in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 35 increasing their positions, 36 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more capital invested

Capital invested by funds: $223M → $255M (+$31.4M)

3% less repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 36

7% less funds holding

Funds holding: 96 → 89 (-7)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
89
Holders Change
-7
Holders Change %
-7.29%
% of All Funds
2.22%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
6
Increased
35
Reduced
36
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$20M
2
WCM
Wedge Capital Management
North Carolina
+$2.02M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$1.73M
4
Renaissance Technologies
Renaissance Technologies
New York
+$1.05M
5
AQR Capital Management
AQR Capital Management
Connecticut
+$1.03M

Top Sellers

Rank Fund Capital Flow
1
RCMC
RK Capital Management (Colorado)
Colorado
-$3.94M
2
SEI Investments
SEI Investments
Pennsylvania
-$2.2M
3
Wells Fargo
Wells Fargo
California
-$917K
4
TC
TFS Capital
Pennsylvania
-$908K
5
Two Sigma Investments
Two Sigma Investments
New York
-$655K
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
26
AllianceBernstein
Tennessee
$2.24M +$1.73M +32,685 +402%
RA
27
Royce & Associates
New York
$2.16M -$296K -5,600 -12%
First Manhattan
28
First Manhattan
New York
$2.15M -$106K -2,000 -5%
GC
29
Globeflex Capital
California
$2.14M +$233K +4,400 +13%
Charles Schwab
30
Charles Schwab
California
$2.1M -$251K -4,739 -11%
WCM
31
Wedge Capital Management
North Carolina
$2.09M +$2.02M +38,200 New
Russell Investments Group
32
Russell Investments Group
United Kingdom
$1.89M +$221K +4,171 +14%
TCIM
33
TIAA CREF Investment Management
New York
$1.87M -$30.3K -572 -2%
PNC Financial Services Group
34
PNC Financial Services Group
Pennsylvania
$1.84M -$23.9K -451 -1%
GCP
35
GSA Capital Partners
United Kingdom
$1.8M -$556K -10,500 -24%
FQ
36
First Quadrant
California
$1.72M -$123K -2,327 -7%
American Century Companies
37
American Century Companies
Missouri
$1.65M -$140K -2,644 -8%
PI
38
Putnam Investments
Massachusetts
$1.62M -$183K -3,457 -10%
CCM
39
Cadence Capital Management
Massachusetts
$1.46M +$256K +4,840 +22%
CAM
40
ClariVest Asset Management
California
$1.35M +$750K +14,175 +135%
CI
41
Cigna Investments
Connecticut
$1.17M – – –
ACM
42
Ativo Capital Management
Illinois
$1.07M – – –
Two Sigma Advisers
43
Two Sigma Advisers
New York
$981K -$222K -4,200 -19%
SCA
44
Secor Capital Advisors
New York
$941K -$30.5K -577 -3%
IP
45
Isthmus Partners
Wisconsin
$926K -$7.99K -151 -0.9%
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$919K -$52.9K -1,000 -6%
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$868K +$45.1K +852 +6%
TC
48
TFS Capital
Pennsylvania
$862K -$908K -17,145 -52%
Two Sigma Investments
49
Two Sigma Investments
New York
$858K -$655K -12,369 -44%
ADEF
50
Adams Diversified Equity Fund
Maryland
$817K +$21.2K +400 +3%
1
2
3 4

BSTC Hedge Fund Activity: Q1 2017 in Review

89 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q1 2017, worth a combined $255M — up 14% from $223M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of BSTC and 6 opened new positions — a net loss of 2 holders — while 36 trimmed existing stakes and 35 added.

The largest buyer was BlackRock, adding an estimated $20M. The largest seller was RK Capital Management (Colorado), exiting entirely with an estimated $3.94M sold.

  • 89 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q1 2017, down from 96 in Q4 2016.
  • Funds reported $255M of BioSpecifics Technologies Corp. stock for Q1 2017, up 14% quarter-over-quarter.
  • 6 funds opened new BioSpecifics Technologies Corp. positions in Q1 2017 and 8 closed out, a net change of -2 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q1 2017 was BlackRock, an estimated $20M added.
  • The largest BioSpecifics Technologies Corp. seller in Q1 2017 was RK Capital Management (Colorado), an estimated $3.94M sold.

Based on aggregated 13F filings for Q1 2017.